Skip to main content
Erschienen in: Neurological Sciences 9/2022

07.05.2022 | Original Article

Pathological changes of the sural nerve in patients with familial episodic pain syndrome

verfasst von: Yilei Zheng, Pengcheng Huang, Shumeng Li, Kaiyan Jiang, Binbin Zhou, Xin Fang, Meihong Zhou, Daojun Hong, Min Zhu

Erschienen in: Neurological Sciences | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Familial episodic pain syndrome type 3 (FEPS3) is an inherited disorder characterized by the early-childhood onset of severe episodic pain that primarily affects the distal extremities. As skin biopsy has revealed a reduction in intraepidermal nerve fiber density and degeneration of the unmyelinated axons, it remains unclear whether FEPS3 patients have pathological changes in the peripheral nerve.

Methods

The clinical features of patients with FEPS3 were summarized in a large autosomal dominant family. Sural nerve biopsies were conducted in two patients. Whole exome sequencing (WES) was performed in the index patient. Sanger sequencing was used to analyze family co-segregation.

Results

Fourteen members exhibited typical and uniform clinical phenotypes characterized by length-dependent and age-dependent severe episodic pain affecting the distal extremities, which can be relieved with anti-inflammatory medicine. The WES revealed a heterozygous mutation c.665G > A (p.R222H) in the SCN11A gene, which was co-segregated with the clinical phenotype in this family. A sural biopsy in patient V:1, who was experiencing episodic pain at 16 years old, showed normal structure, while the sural nerve in patient IV:1, whose pain attack had completely diminished at 42 years old, displayed a decrease of the density of unmyelinated axons with the axonal degeneration.

Conclusions

The clinical phenotype of FEPS3 showed distinctive characteristics that likely arise from dysfunctional nociceptive neurons that lack detectable pathological alterations in the nerve fibers. Nevertheless, long-term dysfunction of the Nav1.9 channel may cause degeneration of the unmyelinated fibers in FEPS3 patient with pain remission.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zhang XY, Wen J, Yang W et al (2013) Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet 93(5):957–966CrossRef Zhang XY, Wen J, Yang W et al (2013) Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet 93(5):957–966CrossRef
2.
Zurück zum Zitat Okuda H, Noguchi A, Kobayashi H et al (2016) Infantile pain episodes associated with novel Nav1.9 mutations in familial episodic pain syndrome in Japanese families. PLoS One 11(5):e0154827CrossRef Okuda H, Noguchi A, Kobayashi H et al (2016) Infantile pain episodes associated with novel Nav1.9 mutations in familial episodic pain syndrome in Japanese families. PLoS One 11(5):e0154827CrossRef
3.
Zurück zum Zitat Leipold E, Hanson-Kahn A, Frick M et al (2015) Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant. Nat Commun 6:10049CrossRef Leipold E, Hanson-Kahn A, Frick M et al (2015) Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant. Nat Commun 6:10049CrossRef
4.
Zurück zum Zitat Kabata R, Okuda H, Noguchi A et al (2018) Familial episodic limb pain in kindreds with novel Nav1.9 mutations. PLoS One 13(12):e0208516CrossRef Kabata R, Okuda H, Noguchi A et al (2018) Familial episodic limb pain in kindreds with novel Nav1.9 mutations. PLoS One 13(12):e0208516CrossRef
5.
Zurück zum Zitat Leng XR, Qi XH, Zhou YT et al (2017) Gain-of-function mutation p.Arg225Cys in SCN11A causes familial episodic pain and contributes to essential tremor. J Hum Genet 62(6):641–646CrossRef Leng XR, Qi XH, Zhou YT et al (2017) Gain-of-function mutation p.Arg225Cys in SCN11A causes familial episodic pain and contributes to essential tremor. J Hum Genet 62(6):641–646CrossRef
6.
Zurück zum Zitat Huang J, Estacion M, Zhao P et al (2019) A novel gain-of-function Nav1.9 mutation in a child with episodic pain. Front Neurosci 13:918CrossRef Huang J, Estacion M, Zhao P et al (2019) A novel gain-of-function Nav1.9 mutation in a child with episodic pain. Front Neurosci 13:918CrossRef
7.
Zurück zum Zitat Kremeyer B, Lopera F, Cox JJ et al (2010) A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 66(5):671–680CrossRef Kremeyer B, Lopera F, Cox JJ et al (2010) A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 66(5):671–680CrossRef
8.
Zurück zum Zitat Faber CG, Lauria G, Merkies IS et al (2012) Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci USA 109(47):19444–19449CrossRef Faber CG, Lauria G, Merkies IS et al (2012) Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci USA 109(47):19444–19449CrossRef
9.
Zurück zum Zitat Bennett DL, Clark AJ, Huang J et al (2019) The role of voltage-gated sodium channels in pain signaling. Physiol Rev 99(2):1079–1151CrossRef Bennett DL, Clark AJ, Huang J et al (2019) The role of voltage-gated sodium channels in pain signaling. Physiol Rev 99(2):1079–1151CrossRef
10.
Zurück zum Zitat Han C, Yang Y, Te Morsche RH et al (2017) Familial gain-of-function Nav1.9 mutation in a painful channelopathy. J Neurol Neurosurg Psychiatry 88(3):233–240CrossRef Han C, Yang Y, Te Morsche RH et al (2017) Familial gain-of-function Nav1.9 mutation in a painful channelopathy. J Neurol Neurosurg Psychiatry 88(3):233–240CrossRef
11.
Zurück zum Zitat Castoro R, Simmons M, Ravi V et al (2018) SCN11A Arg225Cys mutation causes nociceptive pain without detectable peripheral nerve pathology. Neurol Genet 4(4):e255CrossRef Castoro R, Simmons M, Ravi V et al (2018) SCN11A Arg225Cys mutation causes nociceptive pain without detectable peripheral nerve pathology. Neurol Genet 4(4):e255CrossRef
12.
Zurück zum Zitat Sambuughin N, Ren M, Capacchione JF et al (2018) Multifactorial origin of exertional rhabdomyolysis, recurrent hematuria, and episodic pain in a service member with sickle cell trait. Case Rep Genet 2018:6898546PubMedPubMedCentral Sambuughin N, Ren M, Capacchione JF et al (2018) Multifactorial origin of exertional rhabdomyolysis, recurrent hematuria, and episodic pain in a service member with sickle cell trait. Case Rep Genet 2018:6898546PubMedPubMedCentral
13.
Zurück zum Zitat Huang J, Han C, Estacion M et al (2014) Gain-of-function mutations in sodium channel Na(v)19 in painful neuropathy. Brain 137:1627–1642CrossRef Huang J, Han C, Estacion M et al (2014) Gain-of-function mutations in sodium channel Na(v)19 in painful neuropathy. Brain 137:1627–1642CrossRef
14.
Zurück zum Zitat Eijkenboom I, Sopacua M, Hoeijmakers JGJ et al (2019) Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. J Neurol Neurosurg Psychiatry 90(3):342–352CrossRef Eijkenboom I, Sopacua M, Hoeijmakers JGJ et al (2019) Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. J Neurol Neurosurg Psychiatry 90(3):342–352CrossRef
15.
Zurück zum Zitat Han C, Yang Y, de Greef BT et al (2015) The Domain II S4–S5 Linker in Nav1.9: A missense mutation enhances activation, impairs fast inactivation, and produces human painful neuropathy. Neuromolecular Med 17:158–169CrossRef Han C, Yang Y, de Greef BT et al (2015) The Domain II S4–S5 Linker in Nav1.9: A missense mutation enhances activation, impairs fast inactivation, and produces human painful neuropathy. Neuromolecular Med 17:158–169CrossRef
16.
Zurück zum Zitat Ginanneschi F, Rubegni A, Moro F et al (2019) SCN11A variant as possible pain generator in sensory axonal neuropathy. Neurol Sci 40:1295–1297CrossRef Ginanneschi F, Rubegni A, Moro F et al (2019) SCN11A variant as possible pain generator in sensory axonal neuropathy. Neurol Sci 40:1295–1297CrossRef
17.
Zurück zum Zitat King MK, Leipold E, Goehringer JM et al (2017) Pain insensitivity: distal S6-segment mutations in NaV1.9 emerge as critical hotspot. Neurogenetics 18:179–181CrossRef King MK, Leipold E, Goehringer JM et al (2017) Pain insensitivity: distal S6-segment mutations in NaV1.9 emerge as critical hotspot. Neurogenetics 18:179–181CrossRef
18.
Zurück zum Zitat Leipold E, Liebmann L, Korenke GC et al (2013) A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 45:1399–1404CrossRef Leipold E, Liebmann L, Korenke GC et al (2013) A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 45:1399–1404CrossRef
19.
Zurück zum Zitat Huang J, Vanoye CG, Cutts A et al (2017) Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability. J Clin Invest 127:2805–2814CrossRef Huang J, Vanoye CG, Cutts A et al (2017) Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability. J Clin Invest 127:2805–2814CrossRef
20.
Zurück zum Zitat Poojary S, Jaiswal S, Shah KS et al (2020) Sisters with no pain, no tears: a report of a new variant of hereditary sensory and autonomic neuropathy (Type IX) caused by a novel SCN11A mutation. Indian J Dermatol 65:299–303CrossRef Poojary S, Jaiswal S, Shah KS et al (2020) Sisters with no pain, no tears: a report of a new variant of hereditary sensory and autonomic neuropathy (Type IX) caused by a novel SCN11A mutation. Indian J Dermatol 65:299–303CrossRef
21.
Zurück zum Zitat Zu M, Guo WW, Cong T et al (2021) SCN11A gene deletion causes sensorineural hearing loss by impairing the ribbon synapses and auditory nerves. BMC Neurosci 22:18CrossRef Zu M, Guo WW, Cong T et al (2021) SCN11A gene deletion causes sensorineural hearing loss by impairing the ribbon synapses and auditory nerves. BMC Neurosci 22:18CrossRef
22.
Zurück zum Zitat O’Donnell AM, Coyle D, Puri P (2016) Decreased Nav1.9 channel expression in Hirschsprung’s disease. J PediatrSurg 51(9):1458–1461 O’Donnell AM, Coyle D, Puri P (2016) Decreased Nav1.9 channel expression in Hirschsprung’s disease. J PediatrSurg 51(9):1458–1461
23.
Zurück zum Zitat Bennett DL, Woods CG (2014) Painful and painless channelopathies. Lancet Neurol 13(6):587–599CrossRef Bennett DL, Woods CG (2014) Painful and painless channelopathies. Lancet Neurol 13(6):587–599CrossRef
24.
Zurück zum Zitat Wadhawan S, Pant S, Golhar R et al (2017) NaV channel variants in patients with painful and nonpainful peripheral neuropathy. Neurol Genet 3(6):e207CrossRef Wadhawan S, Pant S, Golhar R et al (2017) NaV channel variants in patients with painful and nonpainful peripheral neuropathy. Neurol Genet 3(6):e207CrossRef
25.
Zurück zum Zitat Klein-Weigel PF, Volz TS, Richter JG (2018) Erythromelalgia. Vasa 47(2):91–97CrossRef Klein-Weigel PF, Volz TS, Richter JG (2018) Erythromelalgia. Vasa 47(2):91–97CrossRef
26.
Zurück zum Zitat Fertleman CR, Baker MD, Parker KA et al (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52(5):767–774CrossRef Fertleman CR, Baker MD, Parker KA et al (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52(5):767–774CrossRef
27.
Zurück zum Zitat Zhang Z, Schmelz M, Segerdahl M et al (2014) Exonic mutations in SCN9A (NaV17) are found in a minority of patients with erythromelalgia. Scand J Pain 5(4):217–225CrossRef Zhang Z, Schmelz M, Segerdahl M et al (2014) Exonic mutations in SCN9A (NaV17) are found in a minority of patients with erythromelalgia. Scand J Pain 5(4):217–225CrossRef
28.
Zurück zum Zitat Takahashi K, Ohba T, Okamoto Y et al (2021) E44Q mutation in NaV17 in a patient with infantile paroxysmal knee pain: electrophysiological analysis of voltage-dependent sodium current. Heliyon 7(6):e07396CrossRef Takahashi K, Ohba T, Okamoto Y et al (2021) E44Q mutation in NaV17 in a patient with infantile paroxysmal knee pain: electrophysiological analysis of voltage-dependent sodium current. Heliyon 7(6):e07396CrossRef
29.
Zurück zum Zitat Gawlak M, Szulczyk B, Berłowski A et al (2017) Age-dependent expression of Nav19 channels in medial prefrontal cortex pyramidal neurons in rats. Dev Neurobiol 77(12):1371–1384CrossRef Gawlak M, Szulczyk B, Berłowski A et al (2017) Age-dependent expression of Nav19 channels in medial prefrontal cortex pyramidal neurons in rats. Dev Neurobiol 77(12):1371–1384CrossRef
30.
Zurück zum Zitat Ebbinghaus M, Tuchscherr L, Segond von Banchet G et al (2020) Gain-of-function mutation in SCN11A causes itch and affects neurogenic inflammation and muscle function in Scn11a+/L799P mice. PLoS One 15(8):e0237101CrossRef Ebbinghaus M, Tuchscherr L, Segond von Banchet G et al (2020) Gain-of-function mutation in SCN11A causes itch and affects neurogenic inflammation and muscle function in Scn11a+/L799P mice. PLoS One 15(8):e0237101CrossRef
31.
Zurück zum Zitat Sharkey LM, Cheng X, Drews V et al (2009) The ataxia3 mutation in the N-terminal cytoplasmic domain of sodium channel Na(v)1.6 disrupts intracellular trafficking. J Neurosci 29(9):2733–2741CrossRef Sharkey LM, Cheng X, Drews V et al (2009) The ataxia3 mutation in the N-terminal cytoplasmic domain of sodium channel Na(v)1.6 disrupts intracellular trafficking. J Neurosci 29(9):2733–2741CrossRef
Metadaten
Titel
Pathological changes of the sural nerve in patients with familial episodic pain syndrome
verfasst von
Yilei Zheng
Pengcheng Huang
Shumeng Li
Kaiyan Jiang
Binbin Zhou
Xin Fang
Meihong Zhou
Daojun Hong
Min Zhu
Publikationsdatum
07.05.2022
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 9/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06107-7

Weitere Artikel der Ausgabe 9/2022

Neurological Sciences 9/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.